Ipratropium Nasal 0.03 and Lorcaserin Extended-Release Tablets
Determining the interaction of Ipratropium Nasal 0.03 and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ipratropium nasal
Brand name: Atrovent Nasal
Synonyms: Ipratropium nasal, Ipratropium (Nasal)
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ipratropium Nasal 0.03-Lorcaserin Hydrochloride
- Ipratropium Nasal 0.03-Lorcaserin Tablets
- Ipratropium Nasal 0.03-Lorcet
- Ipratropium Nasal 0.03-Lorcet Plus
- Ipratropium Nasal 0.03-Lorcet Tablets
- Ipratropium Nasal 0.03-Lorlatinib
- Lorcaserin Extended-Release Tablets-Ipratropium Nasal 0.06
- Lorcaserin Extended-Release Tablets-Ipratrovent Sterules
- Lorcaserin Extended-Release Tablets-Iprivask
- Lorcaserin Extended-Release Tablets-IQ Dental Mepivacaine
- Lorcaserin Extended-Release Tablets-Irbesartan
- Lorcaserin Extended-Release Tablets-Irbesartan and Hydrochlorothiazide